Better use of preventative measures and programmes can have a significant cost reducing impact for employers, according to a new report by MAXIS Global Benefits Network (MAXIS).
The report found that musculoskeletal (MSK) conditions were the most expensive claims drivers for multinational employers and accounted for 12% of private medical claims costs for multinationals worldwide, despite the impact of Covid-19. MSK conditions were ahead of respiratory diseases (11.5%), digestive conditions (10.3%), neoplastic diseases (9.1%) and genitourinary conditions (7.1%). The analysis, based on medical claims data from MAXIS' network of local insurance companies, looked at the top drivers of cost in diagnostic and benefits categories both at a regional level and for ea...
To continue reading this article...
Join COVER for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.
